Elena Maccarini

TL;DR: The recent report of SARS‐CoV‐2 presence in semen samples of six patients, including two subjects who were recovering from the clinical disease, re‐opened the discussion on possible male genital tract infection, virus shedding in semen, sexual transmission and safety of fertility treatments during the pandemic period.

TL;DR: In this paper, the authors investigated whether oral antioxidant supplementation improved the reproductive competence of men who had had low fertilization rates in their previous intracytoplasmic sperm injection (ICSI) cycles without azoospermia or severe oligozoospermia and any identifiable andrological disease.

TL;DR: The semen parameters following COVID-19 vaccination did not reflect any causative detrimental effect from vaccination, and for the first time it is demonstrated that this applies to both mRNA and viral-vector vaccines.

TL;DR: Beneficial effects of hyaluronic acid‐based selection of spermatozoa for intracytoplasmic sperm injection (ICSI) are still controversial, and further studies are needed to categorize patients that might benefit from such a method.

TL;DR: In this paper, the authors report their 15 years of experience, the clinical outcomes of ART as well as neonatal characteristics of babies born, and retrospectively review 682 oncological patients who were referred to their center from 2004 to 2019 for fertility preservation.